A Comparative Study for License Application Regulations on Proprietary Chinese Medicines in Hong Kong and Canada.

ABSTRACT: Ethnopharmacological Relevance: Chinese Medicine plays a symbolic role among traditional medicines. As Chinese Medicine products are widely used around the globe, regulations for Chinese Medicine products are often used as models for the efficient regulation of natural products that are safe, and high-quality. Aim of the Study: We aimed to compare the regulatory registration requirements for Proprietary Chinese Medicines in Hong Kong and Canada. Materials and Methods: We compared registration requirements for Proprietary Chinese Medicine in Hong Kong and Canada based on publicly available information provided by the respective Regulators. A marketed product, Zhizhu Kuanzhong Capsule (SFDA approval number Z20020003; NPN approval number 80104354), was used as a case stud

SUBMITTER: Zhong LLD 

PROVIDER: S-EPMC7985161 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature